Howard Fillit
Howard Fillit, MD, is the co-founder and chief science officer of the Alzheimer’s Drug Discovery Foundation in New York. He is an influential figure in Alzheimer's research, advocating for the advancement of treatments and prevention strategies for the disease. Fillit was recently mentioned in the news for commenting on a study that suggests early treatment with anti-amyloid medications could delay Alzheimer's onset, highlighting a shift towards prevention in Alzheimer's research.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Howard Fillit, MD, co-founder and chief science officer at the Alzheimer’s Drug Discovery Foundation in New York, noted that the study shows for the first time that early treatment can delay the onset of Alzheimer’s.
8